IRIX : Summary for IRIDEX Corporation - Yahoo Finance

U.S. Markets closed

IRIDEX Corporation (IRIX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
15.09+0.32 (+2.17%)
At close: 4:00PM EST
People also watch
CUTRESMCDRADMSONSPNC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close14.77
Open14.78
Bid0.00 x
Ask0.00 x
Day's Range14.68 - 15.18
52 Week Range8.92 - 16.64
Volume22,877
Avg. Volume43,914
Market Cap170.46M
Beta0.86
PE Ratio (TTM)-328.04
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cubelast month

    ETFs with exposure to IRIDEX Corp. : January 19, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to IRIDEX Corp. Here are 5 ETFs with the largest exposure to IRIX-US. Comparing the performance and risk of IRIDEX Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • PR Newswirelast month

    IRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full Year

    MOUNTAIN VIEW, Calif., Jan. 9, 2017 /PRNewswire/ -- IRIDEX Corporation (IRIX) today reported preliminary revenues of approximately $12.4 to $12.5 million and $46.0 to $46.1 million for the fourth quarter and full year 2016, respectively, meeting the previously provided quarterly and full year guidance provided by the Company.  Revenue growth compared to fourth quarter and full year 2015 was driven by the Company's new flagship Cyclo G6™ glaucoma laser platform that is powered by the Company's proprietary MicroPulse™ technology. The Company expects to release its complete fourth quarter and full year 2016 results in early March 2017, at which time, the Company will provide guidance for full year 2017.

  • PR Newswire2 months ago

    IRIDEX Corporation Prices Public Offering of Common Stock

    MOUNTAIN VIEW, Calif., Dec. 9, 2016 /PRNewswire/ -- IRIDEX Corporation (IRIX) today announced the pricing of its underwritten public offering of an aggregate of 1.15 million shares of common stock at a price of $14.00 per share, $0.01 par value (the "Offering" with such shares being the "Shares").  IRIDEX expects to receive gross proceeds of $16.1 million, before deducting underwriting discounts and other estimated offering expenses. IRIDEX has also granted the underwriters a 30-day option to purchase up to 172,500 shares of common stock to cover over-allotments, if any. Roth Capital Partners is acting as sole manager for the Offering.